Status:
COMPLETED
Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
Up to 120 years
Brief Summary
RATIONALE: Studying samples of urine and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPO...
Detailed Description
OBJECTIVES: * To determine the association between the genotype for 4 metabolic enzymes (e.g., CYP1A1, GSTM, GSTT, and GSTP) in women with newly diagnosed breast cancer that play key roles in the met...
Eligibility Criteria
Inclusion
- Newly diagnosed breast cancer
- Planning to undergo a diagnostic biopsy or surgery
- Must have tumor tissue available
- Hormone receptor status not specified
- More than 6 months since prior chemotherapy or radiotherapy
- Pre- or post-menopausal
Exclusion
- Psychiatric history that would preclude giving informed consent
Key Trial Info
Start Date :
November 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
1104 Patients enrolled
Trial Details
Trial ID
NCT00766454
Start Date
November 1 1998
End Date
January 1 2010
Last Update
August 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157-1096